407 related articles for article (PubMed ID: 33123281)
1. Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy.
Han J; Gao L; Wang J; Wang J
J Cancer; 2020; 11(23):6902-6915. PubMed ID: 33123281
[TBL] [Abstract][Full Text] [Related]
2. Aptamers as an approach to targeted cancer therapy.
Mahmoudian F; Ahmari A; Shabani S; Sadeghi B; Fahimirad S; Fattahi F
Cancer Cell Int; 2024 Mar; 24(1):108. PubMed ID: 38493153
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
[TBL] [Abstract][Full Text] [Related]
4. SELEX methods on the road to protein targeting with nucleic acid aptamers.
Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
[TBL] [Abstract][Full Text] [Related]
5. Nucleic acid aptamers in diagnosis of colorectal cancer.
Ahmadyousefi Y; Malih S; Mirzaee Y; Saidijam M
Biochimie; 2019 Jan; 156():1-11. PubMed ID: 30244135
[TBL] [Abstract][Full Text] [Related]
6. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
Macedo B; Cordeiro Y
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
[TBL] [Abstract][Full Text] [Related]
7. Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology.
Chen C; Zhou S; Cai Y; Tang F
NPJ Precis Oncol; 2017; 1(1):37. PubMed ID: 29872716
[TBL] [Abstract][Full Text] [Related]
8. DNA and RNA aptamers: from tools for basic research towards therapeutic applications.
Ulrich H; Trujillo CA; Nery AA; Alves JM; Majumder P; Resende RR; Martins AH
Comb Chem High Throughput Screen; 2006 Sep; 9(8):619-32. PubMed ID: 17017882
[TBL] [Abstract][Full Text] [Related]
9. The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature.
Nuzzo S; Brancato V; Affinito A; Salvatore M; Cavaliere C; Condorelli G
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764266
[TBL] [Abstract][Full Text] [Related]
10. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
Stoltenburg R; Reinemann C; Strehlitz B
Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
[TBL] [Abstract][Full Text] [Related]
11. Oligonucleotide aptamers: new tools for targeted cancer therapy.
Sun H; Zhu X; Lu PY; Rosato RR; Tan W; Zu Y
Mol Ther Nucleic Acids; 2014 Aug; 3(8):e182. PubMed ID: 25093706
[TBL] [Abstract][Full Text] [Related]
12. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
Wu Z; Xue S; Yang Y
Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
[TBL] [Abstract][Full Text] [Related]
13. Current Advances in Aptamers for Cancer Diagnosis and Therapy.
Hori SI; Herrera A; Rossi JJ; Zhou J
Cancers (Basel); 2018 Jan; 10(1):. PubMed ID: 29301363
[TBL] [Abstract][Full Text] [Related]
14. Clinical applications of nucleic acid aptamers in cancer.
Pei X; Zhang J; Liu J
Mol Clin Oncol; 2014 May; 2(3):341-348. PubMed ID: 24772298
[TBL] [Abstract][Full Text] [Related]
15. A Highlight of Recent Advances in Aptamer Technology and Its Application.
Sun H; Zu Y
Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
[TBL] [Abstract][Full Text] [Related]
16. Generation of Specific Aptamers.
Liu S; Suzuki Y; Inui M
Methods Mol Biol; 2018; 1868():113-121. PubMed ID: 30244458
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
[TBL] [Abstract][Full Text] [Related]
18. Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery.
Narwade M; Shaikh A; Gajbhiye KR; Kesharwani P; Gajbhiye V
Biomater Res; 2023 May; 27(1):42. PubMed ID: 37149607
[TBL] [Abstract][Full Text] [Related]
19. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
[TBL] [Abstract][Full Text] [Related]
20. Applications of Aptamers in the Diagnosis and Treatment of Ovarian Cancer: Progress From 2016 to 2020.
Ruan L; Li X
Front Genet; 2021; 12():683542. PubMed ID: 34589111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
